InvestorsHub Logo
Followers 41
Posts 1440
Boards Moderated 0
Alias Born 04/05/2009

Re: gss2003 post# 2661

Wednesday, 01/18/2017 6:14:46 PM

Wednesday, January 18, 2017 6:14:46 PM

Post# of 3834
Like it says connect the dots. No good reason not to control the company that makes your drug twice as good. You know this was the sameposition they were in with AVASTIN. Anyone remember that DAVANAT make AVASTIN twice as good because it targeted the drug to the cancer cells which are overexpress with GAL-3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News